Libigrow RED DRAGON+ recalled over undeclared sildenafil
- Recall date
- March 19, 2024
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Pyramids Wholesale Inc. recalls libigrow RED DRAGON+, Maximum Strength Formula, 2 capsules per box, UPC 7 05105 83073 5.
- Recall number
- D-0454-2024
- FDA classification
- Class I
- Brand / firm
- Pyramids Wholesale Inc.
- Sold / distributed
- Nationwide in the USA
Why it was recalled
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.
What was recalled
libigrow RED DRAGON+, Maximum Strength Formula, 2 capsules per box, UPC 7 05105 83073 5.
Get recall alerts
Free email alert whenever Pyramids Wholesale Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Pyramids Wholesale Inc.